Pacific Biosciences Of California Debt-to-Assets Ratio Growth & History (PACB)

Pacific Biosciences Of California's debt-to-assets ratio was 0.07 for fiscal 2025.

View full Pacific Biosciences Of California company overview

Pacific Biosciences Of California annual debt-to-assets ratio history

Pacific Biosciences Of California annual debt-to-assets ratio

Fiscal yearPeriod endedDebt-to-assets ratioChangeGrowth
20252025-12-310.070.05+267.66%
20242024-12-310.02−0.00−17.13%
20232023-12-310.02−0.51−95.55%
20222022-12-310.540.06+12.76%
20212021-12-310.480.37+369.21%
20202020-12-310.10−0.32−75.66%
20192019-12-310.420.33+384.08%
20182018-12-310.09−0.01−9.03%
20172017-12-310.09−0.02−18.98%
20162016-12-310.12
20142014-12-310.130.02+13.37%
20132013-12-310.120.07+172.76%
20122012-12-310.040.03+220.58%
20112011-12-310.010.00+34.93%
20102010-12-310.01

Pacific Biosciences Of California debt-to-assets ratio trends

Over the last five fiscal years, Pacific Biosciences Of California's debt-to-assets ratio decreased from 0.10 to 0.07, a change of −0.03. The latest reported quarter, Q2 2026, shows 0.08.

About the metric

What the debt-to-assets ratio means

The debt-to-assets ratio shows the portion of a company’s reported assets financed with interest-bearing debt. It is a leverage measure and should not be confused with total liabilities divided by assets.

Calculation and source

How debt-to-assets is calculated

TickerStat calculates debt-to-assets as total interest-bearing debt divided by total assets at the same reporting-period end. Periods with missing debt or non-positive assets are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Pacific Biosciences Of California source filings ↗

Community posts

It’s quiet here.

No posts about PACB yet. Start the conversation.

Write the first post